The Latest Breaking News from Tempus

Check out these three health-tech stocks with prospects of recovery in 2025 after seeing shares decline significantly in 2024.

TEM surged 35% on Tuesday, fueled by the launch of its AI-powered health app Olivia and news of Nancy Pelosi's disclosed call option position in the stock.

Here’s what could be next for Tempus AI shares.

The Dow Jones rallied on the stock market today. Palantir stock soared on its S&P 500 nod. Cathie Wood snapped up a plunging AI stock.

This AI diagnostics stock is a holding in Wood's ARKK and ARKG ETFs.

Big debuts from Reddit and Astera Labs are raising hope the IPO market has finally rebounded. But it’s still not the soaring, go-go days of 2021.

Ark Invest's latest big biotech bet is down 15% for the year.

The pharmaceutical industry is well-positioned for significant growth in the near future, given the growing demand for medicines and increasing R&D activities. Given the industry's inelastic demand, fundamentally strong pharma stocks AstraZeneca (AZN), Bristol-Myers Squibb (BMY), and GSK plc (GSK) might be solid long-term investments. Continue reading….

The county is in for another big year of tourism if the popular travel and culture magazine's list is anything to go by!